Dow Jones

40 003,59

0,34%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Ligand Pharmaceuticals Incorporated (PK) (LGNZZ)
Ligand Pharmaceuticals Incorporated (PK) (LGNZZ) Actualités

LGNZZ

Ligand Pharmaceuticals (PK) (LGNZZ)

Ligand Pharmaceuticals Incorporated (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:LGNZZ

Date	Heure	Source	Titre	Symbole	Société
14/05/2024	00h14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
13/05/2024	23h32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
08/05/2024	22h07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
07/05/2024	22h03	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
05/06/2020	22h08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
08/05/2020	22h29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
06/05/2020	22h03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
24/04/2020	22h10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
24/04/2020	22h07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
27/02/2020	23h38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
14/02/2020	19h19	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
14/02/2020	17h34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
13/02/2020	17h09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
06/12/2018	22h10	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
24/08/2018	18h41	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
04/07/2018	00h48	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
02/11/2017	11h03	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
15/11/2016	12h06	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
09/11/2016	14h31	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
29/07/2016	22h32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
24/05/2016	19h00	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
25/01/2016	20h39	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
08/01/2016	22h08	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)